Resonance Health Stock Fundamentals
| RSN Stock | EUR 0.12 0.00 0.00% |
RESONANCE HEALTH fundamentals help investors to digest information that contributes to RESONANCE HEALTH's financial success or failures. It also enables traders to predict the movement of RESONANCE Stock. The fundamental analysis module provides a way to measure RESONANCE HEALTH's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to RESONANCE HEALTH stock.
RESONANCE |
RESONANCE HEALTH Company Current Valuation Analysis
RESONANCE HEALTH's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current RESONANCE HEALTH Current Valuation | 11.48 M |
Most of RESONANCE HEALTH's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, RESONANCE HEALTH is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, RESONANCE HEALTH has a Current Valuation of 11.48 M. This is much higher than that of the Other sector and significantly higher than that of the Other industry. The current valuation for all Germany stocks is notably lower than that of the firm.
RESONANCE HEALTH Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining RESONANCE HEALTH's current stock value. Our valuation model uses many indicators to compare RESONANCE HEALTH value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across RESONANCE HEALTH competition to find correlations between indicators driving RESONANCE HEALTH's intrinsic value. More Info.RESONANCE HEALTH is currently regarded number one company in current valuation category among its peers. It also is currently regarded as top stock in price to book category among its peers . The ratio of Current Valuation to Price To Book for RESONANCE HEALTH is about 1,463,498 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the RESONANCE HEALTH's earnings, one of the primary drivers of an investment's value.RESONANCE Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses RESONANCE HEALTH's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of RESONANCE HEALTH could also be used in its relative valuation, which is a method of valuing RESONANCE HEALTH by comparing valuation metrics of similar companies.RESONANCE HEALTH is currently under evaluation in current valuation category among its peers.
RESONANCE Fundamentals
| Current Valuation | 11.48 M | |||
| Price To Book | 7.84 X | |||
| Price To Sales | 21.61 X | |||
| Market Capitalization | 33.56 M | |||
| Total Asset | 11.69 M | |||
| Net Asset | 11.69 M |
About RESONANCE HEALTH Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze RESONANCE HEALTH's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RESONANCE HEALTH using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RESONANCE HEALTH based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Other Information on Investing in RESONANCE Stock
RESONANCE HEALTH financial ratios help investors to determine whether RESONANCE Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in RESONANCE with respect to the benefits of owning RESONANCE HEALTH security.